Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
5d
News Medical on MSNOpioid δ-receptor agonists show promise for treating IBS-like symptomsResearch reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...
Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...
ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment ...
Researchers at the Center for Life Sciences at the Paul Scherrer Institute PSI have for the first time identified structural ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Verywell Health on MSN6d
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer TypeThe FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...
Health and Me on MSN4h
Can Weight Loss Drugs Curb Alcoholism? See What Study SaysResearchers have pointed out on the limited data on the research and have suggested to continue using the three approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results